United Therapeutics announced positive results of their study looking at the role of Tyvaso in patients with pulmonary fibrosis and pulmonary hypertension. This is a landmark event. No study to date has shown positive results in this population. Patients with interstitial lung disease (broad category of lung disorders involving scarring of the … [Read more...]
Staying Fit During the COVID-19 Pandemic
Staying Healthy with Lung Disease Many of you are probably accustomed to exercising regularly. Perhaps you went to pulmonary rehab programs or the local gym. As we are all hunkering down and sheltering in place our usual routines are tipped upside down. This pandemic is not a sprint but rather a marathon and we need to find ways to stay in … [Read more...]
2020 Update on Cough and Pulmonary Fibrosis
Cough is one of the most common symptoms in pulmonary fibrosis. In fact, some patients will come to medical attention seeking help with their cough. In health, coughing is a protective reflex or mechanism that helps keep our airway free of secretions and debris. We may cough voluntarily or coughing may be triggered by irritation of any part of … [Read more...]
Inhaled Nitric Oxide and Pulmonary Fibrosis
Bellerophon Phase 2 Study In November, Bellerophon announced that their phase 2 study of portable inhaled nitric oxide for pulmonary fibrosis led to clinically important improvements for patients. This is great news for the pulmonary fibrosis community. Patients with many different types of pulmonary fibrosis were included in the study. All had to be using … [Read more...]
Managing the Holiday Season with Pulmonary Fibrosis
The holiday season is a time to be surrounded by family and friends. Cocktail parties and family reunions are common. Celebrating with your family and friends often means decorating the house and cooking for many people. While this can be joyous, for patients with pulmonary fibrosis this time of year offers some extra … [Read more...]